Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells

Murray Korc, Bruce E. Magun

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The binding of 125I-labeled epidermal growth factor (EGF) was studied in Panc-I human pancreatic carcinoma cells. At 37°C, binding was rapid and associated with marked endocytosis of the ligand. Bound EGF was sequentially converted to a number of more acidic species as follows: pI 4.55 to pI 4.2, to pI 4.35, to pI 4.0. EGF internalization and processing were blocked at 4°C. EGF did not alter cell growth when Panc-I cells were incubated in the presence of 2 to 10% serum. In contrast, when the serum concentration was lowered to 0.1%, EGF significantly enhanced cell replication after 6 days of culture.

Original languageEnglish (US)
Pages (from-to)1849-1855
Number of pages7
JournalLife Sciences
Volume36
Issue number19
DOIs
StatePublished - May 13 1985
Externally publishedYes

Fingerprint

Epidermal Growth Factor
Cells
Processing
Cell growth
Endocytosis
Serum
Pancreatic Carcinoma
Ligands
Growth

ASJC Scopus subject areas

  • Pharmacology

Cite this

Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells. / Korc, Murray; Magun, Bruce E.

In: Life Sciences, Vol. 36, No. 19, 13.05.1985, p. 1849-1855.

Research output: Contribution to journalArticle

Korc, Murray ; Magun, Bruce E. / Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells. In: Life Sciences. 1985 ; Vol. 36, No. 19. pp. 1849-1855.
@article{8d5faaaba7a64c57a25097952a4552b9,
title = "Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells",
abstract = "The binding of 125I-labeled epidermal growth factor (EGF) was studied in Panc-I human pancreatic carcinoma cells. At 37°C, binding was rapid and associated with marked endocytosis of the ligand. Bound EGF was sequentially converted to a number of more acidic species as follows: pI 4.55 to pI 4.2, to pI 4.35, to pI 4.0. EGF internalization and processing were blocked at 4°C. EGF did not alter cell growth when Panc-I cells were incubated in the presence of 2 to 10{\%} serum. In contrast, when the serum concentration was lowered to 0.1{\%}, EGF significantly enhanced cell replication after 6 days of culture.",
author = "Murray Korc and Magun, {Bruce E.}",
year = "1985",
month = "5",
day = "13",
doi = "10.1016/0024-3205(85)90158-4",
language = "English (US)",
volume = "36",
pages = "1849--1855",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "19",

}

TY - JOUR

T1 - Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells

AU - Korc, Murray

AU - Magun, Bruce E.

PY - 1985/5/13

Y1 - 1985/5/13

N2 - The binding of 125I-labeled epidermal growth factor (EGF) was studied in Panc-I human pancreatic carcinoma cells. At 37°C, binding was rapid and associated with marked endocytosis of the ligand. Bound EGF was sequentially converted to a number of more acidic species as follows: pI 4.55 to pI 4.2, to pI 4.35, to pI 4.0. EGF internalization and processing were blocked at 4°C. EGF did not alter cell growth when Panc-I cells were incubated in the presence of 2 to 10% serum. In contrast, when the serum concentration was lowered to 0.1%, EGF significantly enhanced cell replication after 6 days of culture.

AB - The binding of 125I-labeled epidermal growth factor (EGF) was studied in Panc-I human pancreatic carcinoma cells. At 37°C, binding was rapid and associated with marked endocytosis of the ligand. Bound EGF was sequentially converted to a number of more acidic species as follows: pI 4.55 to pI 4.2, to pI 4.35, to pI 4.0. EGF internalization and processing were blocked at 4°C. EGF did not alter cell growth when Panc-I cells were incubated in the presence of 2 to 10% serum. In contrast, when the serum concentration was lowered to 0.1%, EGF significantly enhanced cell replication after 6 days of culture.

UR - http://www.scopus.com/inward/record.url?scp=0021811111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021811111&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(85)90158-4

DO - 10.1016/0024-3205(85)90158-4

M3 - Article

C2 - 2985903

AN - SCOPUS:0021811111

VL - 36

SP - 1849

EP - 1855

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 19

ER -